Evidence map›Paper›PMID 37471493›Full record

ArticleBrain : a journal of neurology2023

The collective burden of childhood dementia: a scoping review.

Kristina L Elvidge, John Christodoulou, Michelle A Farrar, Dominic Tilden, Megan Maack, Madeline Valeri, Magda Ellis, Nicholas J C Smith, Childhood Dementia Working Group

Registry-linked trialAbstract readScoping Review
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07039084 (A Randomized Cross-over Trial Examining the Efficacy of Implementing a Speech-generating Device for Rare Genetic Conditions), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07039084 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized Cross-over Trial Examining the Efficacy of Implementing a Speech-generating Device for Rare Genetic Conditions

TypeinterventionalSponsorMurdoch Childrens Research InstituteRan2025 to 2027Enrolled38ConditionsGenetic Disease, Nonverbal Communication, Augmentative and Alternative Communication, Rare Genetic DiseaseArmsSpeech-generating device, Control
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Neurodegenerative Diseases in Children: A Comprehensive Review.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Characterizing circulating biomarkers for childhood dementia disorders: A scoping review of clinical trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kristina L ElvidgeChildhood Dementia Initiative, Brookvale, NSW 2100, Australia.ORCID 0000-0002-9763-344X
John ChristodoulouBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.ORCID 0000-0002-8431-0641
Michelle A FarrarDepartment of Neurology, Sydney Children's Hospital Network, Randwick, NSW 2031, Australia.ORCID 0000-0002-4472-0902
Dominic TildenTHEMA Consulting Pty Ltd, Pyrmont, NSW 2009, Australia.ORCID 0000-0001-7397-1770
Megan MaackChildhood Dementia Initiative, Brookvale, NSW 2100, Australia.ORCID 0000-0003-0870-0338
Madeline ValeriTHEMA Consulting Pty Ltd, Pyrmont, NSW 2009, Australia.
Magda EllisTHEMA Consulting Pty Ltd, Pyrmont, NSW 2009, Australia.
Nicholas J C SmithDiscipline of Paediatrics, University of Adelaide, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.ORCID 0000-0003-2409-9239
Childhood Dementia Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood dementia is a devastating and under-recognized group of disorders with a high level of unmet need. Typically monogenic in origin, this collective of individual neurodegenerative conditions are defined by a progressive impairment of neurocognitive function, presenting in childhood and adolescence. This scoping review aims to clarify definitions and conceptual boundaries of childhood dementia and quantify the collective disease burden. A literature review identified conditions that met the case definition. An expert clinical working group reviewed and ratified inclusion. Epidemiological data were extracted from published literature and collective burden modelled. One hundred and seventy genetic childhood dementia disorders were identified. Of these, 25 were analysed separately as treatable conditions. Collectively, currently untreatable childhood dementia was estimated to have an incidence of 34.5 per 100 000 (1 in 2900 births), median life expectancy of 9 years and prevalence of 5.3 per 100 000 persons. The estimated number of premature deaths per year is similar to childhood cancer (0-14 years) and approximately 70% of those deaths will be prior to adulthood. An additional 49.8 per 100 000 births are attributable to treatable conditions that would cause childhood dementia if not diagnosed early and stringently treated. A relational database of the childhood dementia disorders has been created and will be continually updated as new disorders are identified (https://knowledgebase.childhooddementia.org/). We present the first comprehensive overview of monogenic childhood dementia conditions and their collective epidemiology. Unifying these conditions, with consistent language and definitions, reinforces motivation to advance therapeutic development and health service supports for this significantly disadvantaged group of children and their families.

Indexed as

DementiaNeoplasmsNeurodegenerative DiseasesAdolescentChildCost of IllnessHumansPrevalencechildhood-onset dementianeurodegenerationprogressive childhood encephalopathyprogressive intellectual and neurological deteriorationrare neurological diseases

Identifiers

PMID37471493
PMCPMC10629766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.